Effect of Dashmoola Katutrayadi Syrup in the management of Respiratory Allergies in Children

Study Of Immunomodulating Effect Of Dashmoola Katutrayadi Syrup As An Adjuvant In The Management Of Respiratory Allergies In Children-A Single Arm Prospective Clinical Trial - Not applicable

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062324

Enrollment

Registered

2024-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children having cardinal features of respiratory allergy 2. History of at least three episodes in last one year 3. Age group 6-12 years

Exclusion criteria

Exclusion criteria: 1. Severe and complicated cases of respiratory allergies requiring hospitalization 2. Diagnosed case of Tuberculosis, Plural effusion, Emphysema, Lung abscess, Bronchiectasis, Pleurisy, Nasal polyps, Congenital lung/cardiac anomalies 3. Chronic debilitating diseases

Design outcomes

Primary

Measure	Time frame
1.Change in Serum IgETimepoint: 8 weeks	—

Secondary

Measure	Time frame
1.Change in peak expiratory flow rate (PEFR) 2.Change in CBC, ESR, TEC 3. Change in Morbidity score 4. Change in quality of life Timepoint: 8 Weeks	—

Countries

India

Contacts

Public ContactDR ARCHIT KUMAR

NATIONAL INSTITUTE OF AYURVEDA JAIPUR

drnishaojha@gmail.com9468650449

Outcome results